ClinicaliQ Trial Snapshot
- Biofeedback Intervention for Paroxysmal Atrial Fibrillation — Recruiting • Non-phase study • Cardiology / Cardiovascular • NCT07454317.
- What is being tested: A biofeedback intervention system designed to enable daily monitoring of atrial fibrillation (AF) episodes and physical activity levels in patients with paroxysmal AF, incorporating co-design principles and usability testing to optimise user engagement.
- Patient eligibility overview: The trial focuses on individuals with paroxysmal atrial fibrillation who would benefit from enhanced self-monitoring capabilities and real-time feedback about their arrhythmia patterns and activity levels during daily life.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
This project aims to bridge the gap between technology and healthcare by developing a biofeedback intervention that enables daily monitoring of atrial fibrillation episodes and physical activity levels. The main question it aims to answer is: Is a co-designed, usability-tested, bio-feedback intervention aimed at nudging patients with paroxysmal atrial fibrillation to increase physical activity feasible for a larger randomised control trial? The trial is split into two separate phases, each adopting different study designs, data collection, and data analysis methods. Phase 1 Co-design and usability testing: In this phase, we…
Eligibility Snapshot
- : * Participant is willing and able to give informed consent for participation in the study. * Aged 18 or over. * Diagnosed with paroxysmal AF * Deemed medically stable and well managed.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.